chlorambucil has been researched along with Palsy in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Excerpt | Relevance | Reference |
---|---|---|
" (1) MISO and related compounds inhibit drug-metabolising enzymes, as measured by pentobarbitone sleep-time and zoxazolamine paralysis-time." | 3.66 | Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism. ( Lee, FY; Twentyman, PR; Walton, MI; Workman, P, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Workman, P | 1 |
Twentyman, PR | 1 |
Lee, FY | 1 |
Walton, MI | 1 |
1 other study available for chlorambucil and Palsy
Article | Year |
---|---|
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism.
Topics: Aminopyrine; Animals; Chlorambucil; Female; Kidney Function Tests; Male; Metabolic Clearance Rate; M | 1983 |